Barclays analyst Stephanie Davis maintains $McKesson (MCK.US)$ with a buy rating, and maintains the target price at $668.
According to TipRanks data, the analyst has a success rate of 44.8% and a total average return of -4.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $McKesson (MCK.US)$'s main analysts recently are as follows:
The increase in McKesson's share price by 5% has been seen as a response to strong performance figures that challenge the bearish perspective concerning long-term target risks.
Solid performance across all divisions is expected to address any investor worries regarding the company.
McKesson has addressed and alleviated several of the firm's concerns, removing significant uncertainties. The company, along with its peers, has consistently provided robust updates. Large-cap healthcare stocks are presently seen as somewhat undervalued and not widely held. The expectation is set for the company to revert to its recently higher valuation multiples, although a compelling rationale for this is not firmly presented.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
巴克萊銀行分析師Stephanie Davis維持$麥克森 (MCK.US)$買入評級,維持目標價668美元。
根據TipRanks數據顯示,該分析師近一年總勝率為44.8%,總平均回報率為-4.5%。
此外,綜合報道,$麥克森 (MCK.US)$近期主要分析師觀點如下:
麥克森股價上漲5%,被視爲對強勁業績數據的回應,挑戰了關於長期目標風險的看淡觀點。
所有板塊表現均穩健,預計將解決投資者對公司的任何擔憂。
麥克森已經解決和緩解了公司的多項擔憂,消除了重要的不確定性。該公司與同行一直提供穩固的更新。目前,大市值醫療保健股被視爲略顯低估且持有量不廣泛。預期該公司將恢復到最近較高的估值倍數,儘管對此沒有明確的合理解釋。
提示:
TipRanks為獨立第三方,提供金融分析師的分析數據,並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議,僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級,分析師星級代表分析師所有推薦的過往表現,通過分析師的總勝率和平均回報率综合計算得出,星星越多,則該分析師過往表現越優異,最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否,取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合,並根據評級變化對組合進行調整,在近一年中該投資組合所獲得的回報率。